Search clinical trials for: azoximer bromide

Total 881 results

Judith Dixon-Hughes
Cancer Research UK; NHS Greater Glasgow and Clyde

Recruiting

Precision-Panc Master Protocol: Personalising Treatment for Pancreatic Cancer

Neoplasms Pancreatic

United Kingdom
Cairo University

Completed

Effect of Evidence-based Nursing Practices Training Program on the Competency of Nurses Caring for Mechanically Ventilated Patients

Nursing Caries | Competence | Practice Nurse's Scope

Egypt
Alexander Kolevzon

Completed

Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome

Phelan-McDermid Syndrome

United States
Federal University of Minas Gerais

Unknown

Evaluation of the Educational Program of Diabetes Mellitus: Focus on Empowerment

Type 2 Diabetes Mellitus

Brazil
Aswan University Hospital

Unknown

Bilateral Uterine Artery Ligation During the Cesarean Delivery of Twins

Cesarean Section Complications

Egypt
Massachusetts General Hospital

Completed

Effect of Intranasal Oxytocin on Appetite and Caloric Intake in Men and Women

Eating Behavior

United States
New York Medical College
National Institutes of Health (NIH)

Completed

Cardiovagal Baroreflex Deficits Impair Neurovascular Coupling and Cognition in POTS

Orthostatic Intolerance | Postural Orthostatic Tachycardia Syndrome (POTS) | POTS

United States
Boehringer Ingelheim

Completed

Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPD

Pulmonary Disease, Chronic Obstructive

United States
Boehringer Ingelheim

Completed

Measure of the Long Term Influence of SPIRIVA® in Acute Respiratory Disorders

Pulmonary Disease, Chronic Obstructive

France
Boehringer Ingelheim

Completed

Safety and Effectiveness of Spiriva in COPD (Chronic Obstructive Pulmonary Disease) Patients Under the Real Condition of Usual Practice

Pulmonary Disease, Chronic Obstructive

Taiwan
Boehringer Ingelheim

Completed

SPIRIVA in Ususal Care

Pulmonary Disease, Chronic Obstructive

United Kingdom
Royal Free and University College Medical School
Boehringer Ingelheim

Completed

Effect of Tiotropium on Inflammation and Exacerbations in COPD

Chronic Obstructive Pulmonary Disease

United Kingdom
Advantage Silver Dental Arrest, LLC
University of Washington

Completed

Pharmacokinetics of Advantage Arrest

Dental Caries

United States
Neutec Ar-Ge San ve Tic A.Ş

Completed

Comparison of 24 Hour Bronchodilator Efficacy of Tiotropium 18 mcg Delivered Via DISCAIR Versus SPIRIVA 18 µg Delivered Via HANDIHALER® in Patients With Moderate to Severe COPD

COPD
Orion Corporation, Orion Pharma

Completed

Effect of Charcoal on Gastrointestinal Absorption of Tiotropium (TIOBLOCK)

Healthy Volunteer Study

Finland
Hamilton Health Sciences Corporation

Unknown

Study of a Tiotropium Inhaler For Shortness of Breath in Advanced Non-Small Cell Lung Cancer (TIDAL)

NSCLC | Dyspnea

Canada
Boehringer Ingelheim
Pfizer

Completed

Assessment of Health-status of Patients With Chronic Obstructive Pulmonary Disease (COPD) on Maintenance Therapy With Spiriva HH Measured by COPD Assessment Test (CAT) Test

Pulmonary Disease, Chronic Obstructive

Poland
Boehringer Ingelheim

Completed

Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients

Pulmonary Disease, Chronic Obstructive

United States, Argentina, Australia, Austria, Belgium, Brazil, Czech Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Hungary, Ireland, Italy, Japan, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, Philip... and more
Boehringer Ingelheim

Completed

Tiotropium / Respimat One Year Study in COPD.

Pulmonary Disease, Chronic Obstructive

United States, Australia, Brazil, Canada, China, Denmark, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Ireland, Italy, Korea, Republic of, Lithuania, Malaysia, Mexico, Netherlands, Norway, Portugal, Singapore, Slovakia, South... and more
Boehringer Ingelheim

Completed

Pharmacokinetics of the Fixed Dose Combination of Tiotropium Plus BI 54903 Versus the Combination of the Monoproducts of Tiotropium and BI 54903 in Healthy Volunteers

Healthy

Germany
NHS Greater Glasgow and Clyde

Withdrawn

Replacement of Nebulised Ipratropium With Inhaled Tiotropium in Stable Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

United Kingdom
Boehringer Ingelheim

Completed

Specific Use-result Surveillance of Spiriva Respimat in Asthmatics

Asthma

Brazil
Boehringer Ingelheim

Completed

Effect of Spiriva on the Activities of Daily Living Score Recommended in Austrian COPD Guidelines

Pulmonary Disease, Chronic Obstructive

Austria
Boehringer Ingelheim

Completed

A Prescription-Event Monitoring (PEM) Study of Tiotropium

Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim

Completed

Effect of Spiriva® on Health-related Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients Who Stopped Smoking During Treatment.

Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim

Completed

Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPD

Pulmonary Disease, Chronic Obstructive

France
Boehringer Ingelheim

Completed

Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

United States
Boehringer Ingelheim

Completed

Tiotropium (Spiriva) Rehabilitation Study

Pulmonary Disease, Chronic Obstructive

United States
Elpen Pharmaceutical Co. Inc.

Not yet recruiting

QualiTy of Life Evaluation in Patients With ChRonic ObstructIve Pulmonary Disease Who Require Tiotropium as additiOnal treatmeNt. (TRITON)

COPD
Boehringer Ingelheim

Completed

Characteristics of Pts Initiating Spiriva Respimat in Asthma

Asthma

Germany
GlaxoSmithKline

Completed

GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive

Germany, United States
GlaxoSmithKline

Completed

A Randomized, Double Blind, Placebo Controlled, Incomplete Block, Crossover, Dose Ranging Study to Evaluate the Dose Response of GSK573719 Administered Once or Twice Daily Over 7 Days in Patients With Chronic Obstructive Pulmonary Disease (COPD) (AC4115321)

Pulmonary Disease, Chronic Obstructive

United States
3M

Completed

Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With Reference

Healthy
Boehringer Ingelheim

Completed

A Collection of Vital Status and Pulmonary Medication Usage Data for Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Withdrew Prematurely From Tiotropium Inhalation Solution Delivered by the Respimat Inhaler

Pulmonary Disease, Chronic Obstructive

Australia, New Zealand, United Kingdom
Boehringer Ingelheim

Completed

Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory Infection

Pulmonary Disease, Chronic Obstructive

United States
AstraZeneca

Terminated

A Single-dose Study to Investigate the Effects of 4 Different Doses of Inhaled AZD8683 in Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease | COPD

Poland, Sweden
Boehringer Ingelheim

Completed

Comparison of Tiotropium and Ipratropium in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With COPD

Pulmonary Disease, Chronic Obstructive

Korea, Republic of
Novartis

Completed

A Crossover Study to Determine the Effect on Lung Function of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Using Tiotropium as an Active Control

Chronic Obstructive Pulmonary Disease (COPD)

Spain, Germany, South Africa, Australia, Poland, New Zealand, Netherlands
Da, Yuwei, M.D.

Recruiting

Clinical Prognosis and Progression of Myasthenia Gravis Patients

Myasthenia Gravis

China
Marie Stopes International
Population Council; GRM Futures Group

Completed

A Study Comparing Implant Provision by Community Health Extension Workers With Nurses and Midwives in Nigeria

Contraception
Boehringer Ingelheim

Completed

12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD)

Pulmonary Disease, Chronic Obstructive

Sweden
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Multiple Doses of QAX028 in Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease

United States
Novartis

Completed

Safety and Tolerability QAT370 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

Germany
University of Dundee
Almirall Limited

Completed

Evaluation of Long-Acting Muscarinic Antagonists in COPD (MAN04)

Pulmonary Disease, Chronic Obstructive

United Kingdom
3M
Simbec Research

Completed

Two-period 21 Day Cross-over Study to Compare the Pharmacokinetics of Tiotropium From Two Inhalers

Healthy

United Kingdom
The First Affiliated Hospital of Guangzhou Medical...
Boehringer Ingelheim; Rundo International Pharmaceutical Research & Development...

Completed

Tiotropium In Early Chronic Obstructive Pulmonary Disease Patients in China (Tie-COPD)

Chronic Obstructive Pulmonary Disease

China
3M
Quotient Clinical

Completed

Cross-over Study in Volunteers to Compare the Pharmacokinetics of Tiotropium Delivered From Test and Reference Products

Healthy

United Kingdom
Boehringer Ingelheim
Pfizer

Completed

Effects of Tiotropium on Breathing Capacity and Exercise Limitation in Early Stages of Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive

United States, Canada
Mayo Clinic
Pfizer; Boehringer Ingelheim

Completed

Cardiac Limitations in Chronic Obstructive Pulmonary Disease: Benefits of Bronchodilation

Chronic Obstructive Pulmonary Disease | COPD

United States
Korea University Anam Hospital

Recruiting

Impact of Evolocumab as an Additional Lipid-lowering Therapy to Changes in Lipid Core Burden Index of Non-culprit Vulnerable Plaque in Patients Who Underwent Percutaneous Coronary Intervention for the Acute Coronary Syndrome

Acute Coronary Syndrome | Clinical Trial

Korea, Republic of

3

Subscribe